课题基金 / 基金详情

项目摘要

项目成果

MICHAEL J BOECKH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Core C Microbiology and Virology. For the past 31 years, the Microbiology and Virology Core has supported the projects of this Program by creating and maintaining an extensive Infectious Diseases (ID) database. This database has been critical for projects that have Infectious Disease endpoints. Over the years the function and services provided by the Core have expanded, mainly driven by the availability of highly sensitive and quantitative diagnostic capabilities, which made it imperative to have standardized definitions and interpretations of diagnostic test results for the Programs. Therefore, all infection endpoints for clinical trials or studies related to the aims of the projects are discussed with the Core director, the Core provides statistical support and data management for specific ID analyses related to the projects. State-of - the-art diagnostic capabilities are provided and continuous efforts are made to improve diagnostic capabilities for pathogens relevant to hematopoietic cell transplant recipients. The Core also maintains a prospective sample collection to facilitate infection diagnosis using research diagnostic assays. In addition, the Core provides monitoring capabilities for immune reconstitution studies. Specifically, the Core provides the following services: 1. State-of-the-art diagnostic molecular capabilities for the detection of occult infections and pathogen quantitation. These assays will be applied in patients with idiopathic pneumonia syndrome and for optimizing BAL and tissue-based quantitative molecular diagnosis. 2. Provision of data management and statistical services to Project and Core leaders. 3. Data entry and quality control of the IDdatabases. 4. Assistance to Project and Core leaders in defining ID endpoints, including assurance of appropriate use of ID database, and assistance in analysis of ID data. 5. Maintaining a tissue sample repository (BAL and blood). 6. Antigen preparation for T cell assays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
  • 批准号:
    10701856
  • 项目类别:
  • 资助金额:
    $212.01万
  • 财政年份:
    2020
  • 负责人:
    MICHAEL J BOECKH
  • 依托单位:
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
  • 批准号:
    10656536
  • 项目类别:
  • 资助金额:
    $221.68万
  • 财政年份:
    2020
  • 负责人:
    MICHAEL J BOECKH
  • 依托单位:
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究